A PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA REPLACEMENT WITH 5% ALBUMIN IN BETA-AMYLOID PEPTIDE CLEARANCE IN CEREBROSPINAL FLUID, AND ITS EFFECTS IN PATIENTS WITH MILD-MODERATE ALZHEIMER'S DISEASE